Increasing the impact of light-based medicine

Aug. 6, 2014
"Light offers greater potential than electrons, x-rays and nuclear energy," says Robert R. Alfano, Ph.D., a key advisor for Strategies in Biophotonics and a featured speaker at the inaugural event in Boston next month (September 9-11, 2014).
Barbara G 720 5d24f51cc37ec

Light-based techniques have not had as profound an impact on medicine as approaches using other forms of energy, like x-ray, ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET)—and even chemical tests—explains Robert R. Alfano, Ph.D., Distinguished Professor at the City College of the City University of New York.

And yet, "light offers greater potential than electrons, x-rays and nuclear energy," says Alfano, a key advisor for Strategies in Biophotonics and a featured speaker at the inaugural event in Boston next month (September 9-11, 2014). "There is a lot of R&D in the use of light in biomedical areas; however, very limited commercialization."

But an emphasis on commercialization is growing, as evidenced by increasing development of biophotonics-based clinical systems (see the 2014 Medical Design Excellence Awards report), expanded application of currently successful methods (like OCT in dentistry), coverage in the media and in events (for instance, the 2014 BiOS Translational Research virtual symposium), and the launch of Strategies in Biophotonics, the first-ever event dedicated to development and commercialization of optics-based biomedical products.

On Tuesday, August 12, at 2:30 ET, BioOptics World associate editor Lee Dubay will facilitate a live, interactive discussion (through Google Hangout) with Prof. Alfano and myself on relevant trends and how the Strategies in Biophotonics conference will address them. Please join us if you can—and for those who can't, we'll record the discussion and post it afterward.

"What is needed is translation of R&D into new commercially available medical tools for clinical use," says Alfano. "Hopefully, this conference will stimulate this goal."

About the Author

Barbara Gefvert | Editor-in-Chief, BioOptics World (2008-2020)

Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.

Sponsored Recommendations

Achromatic Lenses: High-Quality Custom Optics

March 13, 2025
Ensure clarity and accuracy in your optics systems with Lacroix’s achromatic lenses. Explore how our custom solutions minimize chromatic aberration for perfect results.

Manufacturing Considerations for Tolerancing Aspheres

March 13, 2025
Understand the critical factors in manufacturing aspheres and how Lacroix Optics ensures precise tolerancing in every optical component.

Explore Our Videos: Insights into Precision Optics

March 13, 2025
Get an inside look at Lacroix Optics with our collection of informative videos showcasing our capabilities, innovations, and processes.

Optical Assemblies: Reliable and Precise Solutions

March 13, 2025
Ensure your optical system works seamlessly with Lacroix Optics' custom optical assemblies. Discover the precision and reliability we bring to every project.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!